Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FitMiss is a specialized nutritional supplement brand focused on the health and wellness needs of women. Originally launched in 2013 as a subsidiary of MusclePharm Corporation, the company provides a range of products including protein powders, weight management supplements, and daily multivitamins. Its product formulations are specifically designed to support female physiological requirements, emphasizing lean muscle maintenance and metabolic health without the heavy stimulants often found in male-oriented sports nutrition. Following a corporate restructuring and asset sale of its parent company in 2023, FitMiss continues to be a recognized name in the global consumer health and fitness market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FitMiss.